Researchers evaluated patients age 65 and over who presented at the emergency department with COVID-19 across seven sites throughout the U.S. on or after March 13. In 16 percent (37) of patients with delirium, it was the primary complaint, and 37 percent (84) presented no other typical coronavirus symptoms such as fever or shortness of breath.
Delirium was also linked to worse outcomes, including intensive care unit stay and death.
Potential risk factors associated with delirium include being over the age of 75, living in a nursing or assisted living home, and vision or hearing impairments, among others.
“These findings suggest the clinical importance of including delirium on checklists of presenting symptoms and symptoms of COVID-19 that guide screening, testing and evaluation,” the study said.
More articles on public health:
Pfizer to apply for emergency approval of vaccine today; COVID-19 cases up 26% in 1 week — 5 updates
States with businesses open, closed, mixed amid COVID-19 spike
HIV deaths fell 48% from 2010 to 2017, CDC says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
